BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Visseaux L, Durlach A, Barete S, Beylot-barry M, Bonnet N, Chassine A, Franck N, Herve G, Leclec'h C, Machet L, Ingen-housz-oro S, Petrella T, Vergier B, Ortonne N, Grange F. T-cell papulosis associated with B-cell malignancy: a distinctive clinicopathologic entity. J Eur Acad Dermatol Venereol 2018;32:1469-75. [DOI: 10.1111/jdv.14805] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Maglie R, Grandi V, Antiga E. Response to: “Hematologic-Related Malignancy-Induced Eosinophilic Dermatosis (He Remained): An eosinophilic dermatosis predominantly associated with chronic lymphocytic leukemia”. Journal of the American Academy of Dermatology 2020;82:e15-6. [DOI: 10.1016/j.jaad.2019.08.061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Maglie R, Ugolini F, De Logu F, Nassini R, Simi S, Nardiello P, Pasqualini E, Baroni G, Del Bianco E, Massi D, Antiga E. Overexpression of helper T cell type 2-related molecules in the skin of patients with eosinophilic dermatosis of hematologic malignancy. J Am Acad Dermatol 2021:S0190-9622(21)02090-9. [PMID: 34265409 DOI: 10.1016/j.jaad.2021.07.007] [Reference Citation Analysis]
3 Maglie R, Ugolini F, De Logu F, Simi S, Senatore S, Montefusco F, Nassini R, Massi D, Antiga E. Dupilumab for the treatment of recalcitrant eosinophilic dermatosis of haematologic malignancy. J Eur Acad Dermatol Venereol 2021;35. [DOI: 10.1111/jdv.17232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Alvarez-Payares JC, Molina A, Gallo S, Ramirez J, Hernandez J, Lopez F, Ramirez-Urrea SI, Álvarez C. Immune-Mediated Cutaneous Paraneoplastic Syndromes Associated With Hematologic Malignancies: Skin as a Mirror of Hematologic Neoplasms. Cureus 2021;13:e19538. [PMID: 34934556 DOI: 10.7759/cureus.19538] [Reference Citation Analysis]
5 Maglie R, Grandi V, Massi D, Caproni M, Pimpinelli N, Antiga E. Cutaneous eruptions associated with haematologic malignancies: the need for a unifying nomenclature. J Eur Acad Dermatol Venereol 2019;33:e191-2. [DOI: 10.1111/jdv.15452] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 Mahé A. [What's new in clinical dermatology?]. Ann Dermatol Venereol 2018;145 Suppl 7:VIIS1-VIIS10. [PMID: 30583751 DOI: 10.1016/S0151-9638(18)31283-3] [Reference Citation Analysis]
7 Maglie R, Genovese G, Solimani F, Guglielmo A, Pileri A, Portelli F, Hertl M, Marzano AV, Antiga E. Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review. Am J Clin Dermatol 2020;21:833-54. [PMID: 32813229 DOI: 10.1007/s40257-020-00553-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Meiss F, Technau-Hafsi K, Kern JS, May AM. Eosinophilic dermatosis of hematologic malignancy: Correlation of molecular characteristics of skin lesions and extracutaneous manifestations of hematologic malignancy. J Cutan Pathol 2019;46:175-81. [PMID: 30411384 DOI: 10.1111/cup.13389] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
9 Bailey CAR, Laurain DA, Sheinbein DM, Jones HA, Compton LA, Rosman IS. Eosinophilic folliculitis, eosinophilic dermatosis of hematologic malignancy and acneiform follicular mucinosis: Two case reports and a review of the literature highlighting the spectrum of histopathology. J Cutan Pathol 2021;48:439-50. [PMID: 33617128 DOI: 10.1111/cup.13932] [Reference Citation Analysis]